☆ 4.4 Editorial Material

Toxicity profiles of HER2/neu peptide anticancer vaccines: the picture from Phase I and II clinical trials

EXPERT REVIEW OF VACCINES (2012)

Journal

EXPERT REVIEW OF VACCINES

Volume 11, Issue 6, Pages 637-640

Publisher

EXPERT REVIEWS

DOI: 10.1586/ERV.12.33

Keywords

cancer vaccines; clinical trials; E75; GP2; HER2/neu; li-Key hybrid peptides; multipeptide vaccines; safety

Categories

Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.